Skip to main content

Azenta Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies

Brooks operates two global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise. The Life Sciences business, to be operated under the new Azenta brand, provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. On September 20, 2021, the Company announced the pending sale to Thomas H. Lee Partners of its Semiconductor Solutions Group business, which provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.

Did you know?

Generated $1.1 in free cash flow for every $1 of capital expenditure in FY25.

Current Price

$24.91

+1.38%

GoodMoat Value

$30.79

23.6% undervalued
Profile
Valuation (TTM)
Market Cap$1.14B
P/E-19.71
EV
P/B0.66
Shares Out45.78M
P/Sales1.92
Revenue$594.95M
EV/EBITDA

AZTA (AZTA) — Earnings Call Transcripts

No transcripts available yet

No earnings call transcripts are available for AZTA yet. Check back after the next earnings report.

← Back to AZTA overview